Inventor · disambiguated record
Ting-Fang He
Also filed as: HE TING · HE TING-FANG
4 granted patents·6 pending applications·119 citations·filing 2014–2025
76Inventor score
Files withCALIFORNIA INST OF TECHN5BEIJING IMMUNOCHINA PHARMACEUTICALS CO LTD3BEIJING IMMUNOCHINA PHARMACALS CO LTD1NANJING GENELEAP BIOTECHNOLOGY CO LTD1
Top patents by PatentIndex Score
10 records- 0195US10457980B2Multiplex labeling of molecules by sequential hybridization barcodingCALIFORNIA INST OF TECHN·Filed 2014·Granted Oct 29, 2019·111 cites·21 claims
- 0294US12305224B2Multiplex labeling of molecules by sequential hybridization barcodingCALIFORNIA INST OF TECHN·Filed 2024·Granted May 20, 2025·3 cites·30 claims
- 0388US11473129B2Multiplex labeling of molecules by sequential hybridization barcodingCALIFORNIA INST OF TECHN·Filed 2019·Granted Oct 18, 2022·5 cites·56 claims
- 0480US2025263784A1Multiplex labeling of molecules by sequential hybridization barcodingCALIFORNIA INST OF TECHN·Filed 2025·Application pending·0 cites
- 0579US2023212658A1Multiplex labeling of molecules by sequential hybridization barcodingCALIFORNIA INST OF TECHN·Filed 2022·Application pending·0 cites
- 0660US11951120B2Modification of gene transcription and translation efficiency by 5′UTR sequence variationNANJING GENELEAP BIOTECHNOLOGY CO LTD·Filed 2022·Granted Apr 9, 2024·0 cites·20 claims
- 0759US2024124848A1Stable lentivirus packaging cell line and preparation method thereforBEIJING IMMUNOCHINA PHARMACALS CO LTD·Filed 2021·Application pending·0 cites
- 0846US2024383970A1Antibody specifically binding to strep-tag ii tag and use thereofBEIJING IMMUNOCHINA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 0943US2024336692A1Antibody that specifically binds to bcma and application thereofBEIJING IMMUNOCHINA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1036US2023346937A1Optimization of chimeric antigen receptorBEIJING IMMUNOCHINA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →